Reading Time: < 1 minuteWith a significantly costlier medication for HIV preexposure prophylaxis (PrEP) approved in 2019, a new study examined reasons patients switched to the…
Reading Time: < 1 minuteAfrica CDC Director John Nkengasong discusses the obligations governments and donors in the fight against the spread of HIV. Read More
Reading Time: < 1 minuteThe combination drug regimen of dolutegravir and lamivudine (Dovato, ViiV Healthcare) demonstrated non-inferior efficacy compared to the continuation of a current antiretroviral…
Reading Time: < 1 minuteSixty-five Kenyans have contracted HIV while consistently taking the preventive drugs called Prep, the Ministry of Health has said. Read More
Reading Time: < 1 minuteHuman immunodeficiency virus (HIV) positive women have a greater likelihood of developing cervical cancer than HIV-negative women. Read More
Reading Time: < 1 minuteGreat strides have been made in HIV prevention, treatment and care, since the first case of the viral infection was reported 40…